4.7 Article

Misery Perfusion and Tau Deposition in Atherosclerotic Major Cerebral Artery Disease: A 18F-Florzolotau Positron Emission Tomography Study

Related references

Note: Only part of the references are listed.
Article Neurosciences

High-Contrast In Vivo Imaging of Tau Pathologies in Alzheimer's and Non-Alzheimer's Disease Tauopathies

Kenji Tagai et al.

Summary: A panel of radiochemicals for in vivo PET imaging of tau pathologies in AD has been developed, but sensitive detection of FTLD tau inclusions remains challenging. The imaging probe PM-PBB3 successfully captures diverse tau deposits in AD and FTLD, with increased binding observed in diseased patients in a subsequent clinical PET study. Visual inspection of F-18-PM-PBB3-PET images aids in individually based identification of diverse clinical phenotypes of FTLD on a neuropathological basis.

NEURON (2021)

Review Cell Biology

Tau as a potential therapeutic target for ischemic stroke

Xin Chen et al.

AGING-US (2019)

Article Radiology, Nuclear Medicine & Medical Imaging

18F-FPYBF-2, a new F-18-labelled amyloid imaging PET tracer: first experience in 61 volunteers and 55 patients with dementia

Tatsuya Higashi et al.

ANNALS OF NUCLEAR MEDICINE (2018)

Review Endocrinology & Metabolism

Selective neuronal loss in ischemic stroke and cerebrovascular disease

Jean-Claude Baron et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2014)